TY - JOUR
T1 - Factors Associated with Mortality in Nosocomial Lower Respiratory Tract Infections
T2 - An ENIRRI Analysis
AU - Reyes, Luis Felipe
AU - Torres, Antoni
AU - Olivella-Gomez, Juan
AU - Ibáñez-Prada, Elsa D.
AU - Nseir, Saad
AU - Ranzani, Otavio T.
AU - Povoa, Pedro
AU - Diaz, Emilio
AU - Schultz, Marcus J.
AU - Rodríguez, Alejandro H.
AU - Serrano-Mayorga, Cristian C.
AU - De Pascale, Gennaro
AU - Navalesi, Paolo
AU - Skoczynski, Szymon
AU - Esperatti, Mariano
AU - Coelho, Luis Miguel
AU - Cortegiani, Andrea
AU - Aliberti, Stefano
AU - Caricato, Anselmo
AU - Salzer, Helmut J.F.
AU - Ceccato, Adrian
AU - Civljak, Rok
AU - Soave, Paolo Maurizio
AU - Luyt, Charles Edouard
AU - Korkmaz Ekren, Pervin
AU - Rios, Fernando
AU - Masclans, Joan Ramon
AU - Marin, Judith
AU - Iglesias-Moles, Silvia
AU - Nava, Stefano
AU - Chiumello, Davide
AU - Bos, Lieuwe D.
AU - Artigas, Antonio
AU - Froes, Filipe
AU - Grimaldi, David
AU - Panigada, Mauro
AU - Taccone, Fabio Silvio
AU - Antonelli, Massimo
AU - Martin-Loeches, Ignacio
AU - on behalf of the European Network for ICU-Related Respiratory Infections (ENIRRIs) European Respiratory Society-Clinical Research Collaboration Investigators
PY - 2025/2
Y1 - 2025/2
N2 - Background: Nosocomial lower respiratory tract infections (nLRTIs) are associated with unfavorable clinical outcomes and significant healthcare costs. nLRTIs include hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and other ICU-acquired pneumonia phenotypes. While risk factors for mortality in these infections are critical to guide preventive strategies, it remains unclear whether they vary based on their requirement of invasive mechanical ventilation (IMV) at any point during the hospitalization. Objectives: This study aims to identify risk factors associated with short- and long-term mortality in patients with nLRTIs, considering differences between those requiring IMV and those who do not. Methods: This multinational prospective cohort study included ICU-admitted patients diagnosed with nLRTI from 28 hospitals across 13 countries in Europe and South America between May 2016 and August 2019. Patients were selected based on predefined inclusion and exclusion criteria, and clinical data were collected from medical records. A random forest classifier determined the most optimal clustering strategy when comparing pneumonia site acquisition [ward or intensive care unit (ICU)] versus intensive mechanical ventilation (IMV) necessity at any point during hospitalization to enhance the accuracy and generalizability of the regression models. Results: A total of 1060 patients were included. The random forest classifier identified that the most efficient clustering strategy was based on ventilation necessity. In total, 76.4% of patients [810/1060] received IMV at some point during the hospitalization. Diabetes mellitus was identified to be associated with 28-day mortality in the non-IMV group (OR [IQR]: 2.96 [1.28–6.80], p = 0.01). The 90-day mortality-associated factor was MDRP infection (1.98 [1.13–3.44], p = 0.01). For ventilated patients, chronic liver disease was associated with 28-day mortality (2.38 [1.06–5.31] p = 0.03), with no variable showing statistical and clinical significance at 90 days. Conclusions: The risk factors associated with 28-day mortality differ from those linked to 90-day mortality. Additionally, these factors vary between patients receiving invasive mechanical ventilation and those in the non-invasive ventilation group. This underscores the necessity of tailoring therapeutic objectives and preventive strategies with a personalized approach.
AB - Background: Nosocomial lower respiratory tract infections (nLRTIs) are associated with unfavorable clinical outcomes and significant healthcare costs. nLRTIs include hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and other ICU-acquired pneumonia phenotypes. While risk factors for mortality in these infections are critical to guide preventive strategies, it remains unclear whether they vary based on their requirement of invasive mechanical ventilation (IMV) at any point during the hospitalization. Objectives: This study aims to identify risk factors associated with short- and long-term mortality in patients with nLRTIs, considering differences between those requiring IMV and those who do not. Methods: This multinational prospective cohort study included ICU-admitted patients diagnosed with nLRTI from 28 hospitals across 13 countries in Europe and South America between May 2016 and August 2019. Patients were selected based on predefined inclusion and exclusion criteria, and clinical data were collected from medical records. A random forest classifier determined the most optimal clustering strategy when comparing pneumonia site acquisition [ward or intensive care unit (ICU)] versus intensive mechanical ventilation (IMV) necessity at any point during hospitalization to enhance the accuracy and generalizability of the regression models. Results: A total of 1060 patients were included. The random forest classifier identified that the most efficient clustering strategy was based on ventilation necessity. In total, 76.4% of patients [810/1060] received IMV at some point during the hospitalization. Diabetes mellitus was identified to be associated with 28-day mortality in the non-IMV group (OR [IQR]: 2.96 [1.28–6.80], p = 0.01). The 90-day mortality-associated factor was MDRP infection (1.98 [1.13–3.44], p = 0.01). For ventilated patients, chronic liver disease was associated with 28-day mortality (2.38 [1.06–5.31] p = 0.03), with no variable showing statistical and clinical significance at 90 days. Conclusions: The risk factors associated with 28-day mortality differ from those linked to 90-day mortality. Additionally, these factors vary between patients receiving invasive mechanical ventilation and those in the non-invasive ventilation group. This underscores the necessity of tailoring therapeutic objectives and preventive strategies with a personalized approach.
KW - critical care
KW - mechanical ventilation
KW - nosocomial lower respiratory tract infections
U2 - 10.3390/antibiotics14020127
DO - 10.3390/antibiotics14020127
M3 - Journal article
C2 - 40001371
AN - SCOPUS:85219196945
SN - 2079-6382
VL - 14
JO - Antibiotics
JF - Antibiotics
IS - 2
M1 - 127
ER -